TY - JOUR
T1 - Agreement between pharmaceutical claims data and patient-reported medication use after stroke
AU - Dalli, Lachlan L.
AU - Andrew, Nadine E.
AU - Cadilhac, Dominique A.
AU - Kim, Joosup
AU - Sanfilippo, Frank M.
AU - Kilkenny, Monique F.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - OBJECTIVES: To assess the agreement between pharmaceutical claims data and patient-reported medication use after stroke. METHODS: Claims data from the Pharmaceutical Benefits Scheme were used to estimate medication use for a subset of participants registered in the Australian Stroke Clinical Registry in 2016. Estimates on medication use were validated against patient-reported responses (considered the reference standard). KEY FINDINGS: For antihypertensive and lipid-lowering medications, the sensitivity of claims data was excellent (85-87%) and the specificity was good (73-78%). Whereas for antithrombotic medications, sensitivity was modest (61%), but specificity was excellent (85%). CONCLUSIONS: Pharmaceutical claims data can be used to infer medication use after stroke with mostly good to excellent sensitivity and specificity compared with the patient report.
AB - OBJECTIVES: To assess the agreement between pharmaceutical claims data and patient-reported medication use after stroke. METHODS: Claims data from the Pharmaceutical Benefits Scheme were used to estimate medication use for a subset of participants registered in the Australian Stroke Clinical Registry in 2016. Estimates on medication use were validated against patient-reported responses (considered the reference standard). KEY FINDINGS: For antihypertensive and lipid-lowering medications, the sensitivity of claims data was excellent (85-87%) and the specificity was good (73-78%). Whereas for antithrombotic medications, sensitivity was modest (61%), but specificity was excellent (85%). CONCLUSIONS: Pharmaceutical claims data can be used to infer medication use after stroke with mostly good to excellent sensitivity and specificity compared with the patient report.
KW - administrative claims
KW - healthcare validation study
KW - pharmacoepidemiology
KW - registries
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85116957949&partnerID=8YFLogxK
U2 - 10.1093/ijpp/riab032
DO - 10.1093/ijpp/riab032
M3 - Article
C2 - 34165141
AN - SCOPUS:85116957949
SN - 0961-7671
VL - 29
SP - 397
EP - 399
JO - The International Journal of Pharmacy Practice
JF - The International Journal of Pharmacy Practice
IS - 4
ER -
